Investigators explored the effects of PPARβ/δ agonist on the regeneration of diabetic bone defects and the osteogenic differentiation of rat bone marrow MSCs under a pathological high-glucose condition.
[Stem Cell Research & Therapy]
7992332
EEEEEEEE
items
1
apa
0
default
asc
1
168707
https://www.stemcellsciencenews.com/wp-content/plugins/zotpress/
